Abbott has achieved a significant milestone in cardiac healthcare by securing the CE Mark for its AVEIR dual chamber (DR) leadless pacemaker system in Europe. This groundbreaking device represents the world’s first dual chamber leadless pacemaker, specifically designed to treat individuals with abnormal or slow heart rhythms—a condition affecting approximately 49 million people across the […]
In an exciting development for migraine sufferers, Dr. Reddy’s Laboratories Ltd., a leader in the global pharmaceutical industry, has announced the launch of its groundbreaking, drug-free, non-invasive migraine management device, Nerivio, in Germany. This move, facilitated through its step-down subsidiary betapharm, signifies Dr. Reddy’s Laboratories’ foray into the realm of digital therapeutics in Europe, marking […]
